Intersect ENT, Inc.
Intersect ENT, Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.
About Intersect ENT, Inc.
Intersect ENT, Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by MOMETASONE FUROATE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: sinuva sinus, implant indicated, treatment chronic, nasal polyps, adult patients, years age. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| MOMETASONE FUROATE | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRASINAL | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Intersect ENT, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| Sinuva | MOMETASONE FUROATE | HUMAN PRESCRIPTION DRUG | INTRASINAL |
Frequently asked questions
How many FDA drug products does Intersect ENT, Inc. make?
1 FDA drug label records name Intersect ENT, Inc. as the manufacturer, covering 1 distinct active ingredients.
What active ingredients does Intersect ENT, Inc. produce?
The most frequent active ingredients in this portfolio are MOMETASONE FUROATE.
Are Intersect ENT, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.